Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|April 22, 2024
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trialsAndreas Roller, Iakov I Davydov, Petra C Schwalie, et al.
Blood|August 24, 2012
A novel hierarchical prognostic model of AML solely based on molecular mutationsVera Grossmann, Susanne Schnittger, Alexander Kohlmann, et al.
Journal for Immunotherapy of Cancer|November 14, 2025
Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data martDavid F Lamparter, Virginia C Schmid, Rajat Mohindra, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 8, 2014
Hypothalamic miR-103 protects from hyperphagic obesity in miceIlya A Vinnikov, Karolina Hajdukiewicz, Jürgen Reymann, et al.
Journal for Immunotherapy of Cancer|January 16, 2026
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumorsIgnacio Melero, Neeltje Steeghs, Ulrik Lassen, et al.
Frontiers in Oncology|February 22, 2021
Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor ActivityJohannes Sam, Sara Colombetti, Tanja Fauti, et al.
Frontiers in Oncology|December 17, 2020
Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor ActivityJohannes Sam, Sara Colombetti, Tanja Fauti, et al.
Frontiers in Oncology|March 28, 2025
Mapping MAGE-A4 expression in solid cancers for targeted therapiesChristin Habigt, Sylvie Rottey, Iben Spanggaard, et al.
Cancer Immunology Research|August 9, 2015
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory ReceptorsDaniela S Thommen, Jens Schreiner, Philipp Müller, et al.
Oncoimmunology|April 9, 2016
Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptorJens Schreiner, Daniela S Thommen, Petra Herzig, et al.
Pageof 3